United States Contraceptive Devices Market- Growth, Trends, and Forecast (2020 - 2025)

The United States Contraceptive Devices Market is segmented By Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra-Uterine Device (IUD) and Others), By Gender and Geography.

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The United States Contraceptive Devices Market is expected to register a CAGR of 5.5% during the forecast period. Some of the factors such as the increasing number of unwanted pregnancies and the increasing awareness about sexually transmitted diseases (STDs) are propelling the market growth. As per the United Nations’ 2019 report on contraceptive use by method, in the United States the estimated prevalence of contraceptive use among women of reproductive age (15-49 years) in 2019 was about 13.7% women used contraceptive pills, 2.3% used contraceptive injectables, 2.7% contraceptive implants, and 8.3% intrauterine contraceptive device. Women and couples are using contraceptives to have healthier pregnancies, and space births, and to achieve their desired family size. This is helping in the growth of the contraceptive devices market in the United States.

Scope of the report

As per the scope of the report, contraceptives devices have been barriers that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. They include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide.

By Type
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Device (IUD)
Other Types
By Gender
Male
Female

Report scope can be customized per your requirements. Click here.

Key Market Trends

Condoms are Expected to Dominate the USA Contraceptive Devices Market

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis.

According to the U.S. Centers for Disease Control and Prevention Report, 2017, about one-third of the men or 33.7% said they used a condom the last time they had sex in the United States in 2017. This number had been reported to have increased from 29.5% in 2002, as per the report. Therefore, the increased use of condoms is expected to help the studied segment growth.

To understand key trends, Download Sample Report

Competitive Landscape

The United States Contraceptive Devices Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Bayer Healthcare, AbbVie Inc.(Allergan), Cooper Surgical Inc., Mylan Laboratories, Pfizer Inc., Teva Pharmaceutical Industries Ltd, DKT International, Pregna International Limited, Reckitt Benckiser

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Government Initiatives and Increasing Awareness about Sexually Transmitted Diseases (STDs)

      2. 4.2.2 Rising Rate of Unintended Pregnancies

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects Associated with the Use of Contraceptive Devices

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Condoms

      2. 5.1.2 Diaphragms

      3. 5.1.3 Cervical Caps

      4. 5.1.4 Sponges

      5. 5.1.5 Vaginal Rings

      6. 5.1.6 Intra Uterine Device (IUD)

      7. 5.1.7 Other Types

    2. 5.2 By Gender

      1. 5.2.1 Male

      2. 5.2.2 Female

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc.(Allergan PLC)

      2. 6.1.2 Cooper Surgical Inc.

      3. 6.1.3 Mylan Laboratories

      4. 6.1.4 Pfizer Inc.

      5. 6.1.5 Teva Pharmaceutical Industries Ltd

      6. 6.1.6 DKT International

      7. 6.1.7 Pregna International Limited

      8. 6.1.8 Reckitt Benckiser

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports